Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
3 Warren Buffett Stocks That Are No-Brainer Buys in April
09:06am, Monday, 03'rd Apr 2023 The Motley Fool
Out of Berkshire Hathaway's more than four dozen holdings, there are three stocks that stand out as absolute steals right now.
Johnson & Johnson: Negative Alpha Likely Ahead
08:38am, Monday, 03'rd Apr 2023 Seeking Alpha
Johnson & Johnson's talc lawsuit issues continue. Looming loss of exclusivity on JNJ's top drug can drag revenues. Read why JNJ stock is a Hold.
Surviving Inflation: 5 Perfect Dividend Stocks To Get The Job Done
07:30am, Monday, 03'rd Apr 2023
In this article, we start with a discussion of the importance of inflation protection (in light of current developments) and things to consider before researching individual stocks. I then present fiv
3 Top S&P 500 Stocks Near 52-Week Lows That Look Like Bargains Now
05:27am, Monday, 03'rd Apr 2023
Shares of CVS Health have been beaten down in response to lower COVID-related revenue, but this is only a temporary setback. Medtronic shares offer an above-average dividend yield, and its payout has
Johnson & Johnson: Negative Alpha Likely Ahead
04:38am, Monday, 03'rd Apr 2023
Johnson & Johnson's talc lawsuit issues continue. Looming loss of exclusivity on JNJ's top drug can drag revenues.
Could This Move by Johnson & Johnson Equal Billions for Moderna?
09:30am, Sunday, 02'nd Apr 2023 The Motley Fool
An RSV vaccine could be a driver of blockbuster revenue.
Could This Move by Johnson & Johnson Equal Billions for Moderna?
05:30am, Sunday, 02'nd Apr 2023
J&J is dropping out of the adult RSV vaccine race. This leaves the market to Moderna, Pfizer, and GSK; all three are close to reaching commercialization with their vaccine candidates.
3 Surprisingly Underrated Stocks to Buy in April
10:14am, Saturday, 01'st Apr 2023 The Motley Fool
These drugmakers could deliver greater gains than many investors expect.
3 Surprisingly Underrated Stocks to Buy in April
06:14am, Saturday, 01'st Apr 2023
Axsome Therapeutics has multiple catalysts on the way. Johnson & Johnson is a bargain with its improving growth prospects.
Johnson & Johnson, Procter & Gamble Among 11 Companies To Continue Dividend Growth In Early April
03:52am, Saturday, 01'st Apr 2023
Eleven companies announced annual dividend increases in March. Colgate-Palmolive started its 7th decade of dividend growth in March with a 2% boost. Steel Dynamics followed up last year's 31% boost wi
Long-Term Investors' 9 Favorite Index Funds
10:21pm, Friday, 31'st Mar 2023 The Motley Fool
Here are the nine best index funds to add to your portfolio for steady, low-cost growth.
3 Top Dividend Stocks to Buy Now for an Income-Based Portfolio
04:44pm, Friday, 31'st Mar 2023
The start of a bull market is a good time to look for dividend stocks to buy. Is this the start of a new one?
Johnson & Johnson (JNJ) Could Be a Great Choice
03:45pm, Friday, 31'st Mar 2023 Zacks Investment Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
My Top 10 High Dividend Yield Stocks To Invest In April 2023
02:00pm, Friday, 31'st Mar 2023
In today's article, I will present you with my top 10 high Dividend Yield stocks to invest in for April 2023. The 10 selected picks provide you with an attractive Dividend Yield, a relatively low Payo
Should iShares Russell 1000 Value ETF (IWD) Be on Your Investing Radar?
10:20am, Friday, 31'st Mar 2023 Zacks Investment Research
Style Box ETF report for IWD
